UTHR
UTHR
US91307C1027
United Therapeutics Corporation
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 3.182.700.000 2.877.400.000
10.6%
Cost of Revenue 384.400.000 309.700.000
24.1%
Gross Profit 2.798.300.000 2.567.700.000
9.0%
1.281.100.000 1.119.600.000
14.4%
Operating Income 1.517.200.000 1.448.100.000
4.8%
Pretax Income 1.713.900.000 1.539.000.000
11.4%
Net Income Common Stockholders 1.334.700.000 1.195.100.000
11.7%
-- --
--
-- --
--
ende